Play Live Radio
Next Up:
0:00 0:00
Available On Air Stations

Pfizer Faces Celebrex Fallout

Pfizer is dealing with repercussions of a study linking its painkiller Celebrex to an increased risk of heart trouble. The company will stop airing its ads for the drug in response to a request from the Food and Drug Administration, which is mulling further action. Meanwhile, Pfizer's stock continued to sink on Wall Street. NPR's Snigdha Prakash reports.

Copyright 2004 NPR

Snigdha Prakash
Pieces by National Desk reporter Snigdha Prakash can be heard on NPR's All Things Considered and Morning Edition. The majority of Snigdha's past reports have focused on topics related to entrepreneurship, business, banking and the economy.